Emerging Biopharma

money financing funds
Biotech

Fierce Biotech Fundraising Tracker: Aro, Vivodyne & more

Alongside the new year, we've launched a new Fierce Biotech Fundraising Tracker.
Biotech MA Tracker

Fierce Biotech M&A Tracker 2023: T3, Freeline & more

Nov 22, 2023 10:45am
Jefferies

Optimism at Jefferies, but don't expect IPO boost soon—Sofinnova

Nov 16, 2023 3:00am
IPO initial public offering Wall Street

Lexeo drops share price at last minute to raise $100M IPO

Nov 3, 2023 8:19am
Eli Lilly ESMO pipeline 2023

The ESMO ADC Files: Lilly tries to avoid 'shiny new objects'

Oct 24, 2023 5:45am
gamble bet slots Vegas dice cards poker

Biopharma won’t stop betting big on M&A earnouts as payouts slow

Oct 17, 2023 6:00am
More News

Orphan cell, gene therapies more likely to reach approval: study

Oct 11, 2023 12:00pm

Agomab uses $100M series C to push Crohn's drug through phase 2

Oct 11, 2023 8:50am

After pandemic sugar rush, biotechs eye stigmatized fundraisings

Oct 9, 2023 7:00am

Novo Nordisk's owner widens investment strategy beyond biotech

Oct 6, 2023 9:55am